Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant
The FDA revised the authorizations for two monoclonal antibody treatments to limit their use due to the omicron variant.
The FDA revised the authorizations for two monoclonal antibody treatments to limit their use due to the omicron variant.
以上內容由「Cofacts 真的假的」訊息回報機器人與查證協作社群提供,以 CC授權 姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出,於後續重製或散布時,原社群顯名及每一則查證的出處連結皆必須被完整引用。